Understanding a Comprehensive Blood Panel
What the major sections of a broad panel measure, why trends matter more than single readings, and how reference ranges are constructed — and misread.
Long-form explainers on evaluation, laboratory markers, treatment options and monitoring.
What the major sections of a broad panel measure, why trends matter more than single readings, and how reference ranges are constructed — and misread.
What compounding is, how 503A and 503B pharmacies differ, what FDA oversight does and does not cover, and the questions worth asking before you accept a compounded preparation.
What the evaluation involves, why testosterone's controlled-substance status changes the telehealth pathway, how monitoring works, and the questions to settle before you start.
What each marker on a male hormone panel means, why one low reading is not a diagnosis, and which values a provider weighs most.
What HIPAA covers and what it does not, how tracking technologies became a compliance issue, which state laws add rights, and the practical questions to ask any online clinic.
What peptides are, which ones are actually prescribable, why the FDA's compounding lists matter, and how to read the gap between online enthusiasm and clinical availability.
How androgenetic hair loss works, what finasteride and minoxidil each do, why timing matters more than product choice, and how to assess change honestly.
Titration, gastrointestinal effects, monitoring and the questions worth asking before starting GLP-1 therapy for weight management.
Why gastrointestinal effects are so common on GLP-1 medications, what titration is actually doing, and which symptoms warrant contacting a provider rather than waiting them out.
A practical checklist for assessing an online clinic — licensure, evaluation depth, pharmacy relationships, pricing transparency, and the marketing language that should give you pause.